Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 3
1982 2
1983 4
1984 1
1985 4
1986 6
1987 4
1988 2
1989 4
1990 4
1991 3
1992 10
1993 3
1994 3
1995 6
1996 6
1997 6
1998 5
1999 8
2000 9
2001 7
2002 5
2003 8
2004 5
2005 12
2006 5
2007 11
2008 8
2009 10
2010 13
2011 11
2012 8
2013 8
2014 9
2015 4
2016 1
2018 2
2019 5
2020 6
2021 4
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Lublin FD, et al. Among authors: rudick ra. Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28. Neurology. 2014. PMID: 24871874 Free PMC article.
Beta-interferon for multiple sclerosis.
Rudick RA, Goelz SE. Rudick RA, et al. Exp Cell Res. 2011 May 15;317(9):1301-11. doi: 10.1016/j.yexcr.2011.03.002. Epub 2011 Mar 21. Exp Cell Res. 2011. PMID: 21396360 Review.
Magnetic resonance fingerprinting in multiple sclerosis.
Ontaneda D, Gulani V, Deshmane A, Shah A, Guruprakash DK, Jiang Y, Ma D, Fisher E, Rudick RA, Raza P, Kilbane M, Cohen JA, Sakaie K, Lowe MJ, Griswold MA, Nakamura K. Ontaneda D, et al. Among authors: rudick ra. Mult Scler Relat Disord. 2023 Nov;79:105024. doi: 10.1016/j.msard.2023.105024. Epub 2023 Sep 27. Mult Scler Relat Disord. 2023. PMID: 37783196
Management of multiple sclerosis.
Rudick RA, Cohen JA, Weinstock-Guttman B, Kinkel RP, Ransohoff RM. Rudick RA, et al. N Engl J Med. 1997 Nov 27;337(22):1604-11. doi: 10.1056/NEJM199711273372207. N Engl J Med. 1997. PMID: 9371858 Review. No abstract available.
Measuring disability in relapsing-remitting MS.
Rudick RA, Kappos L. Rudick RA, et al. Neurology. 2010 Jul 27;75(4):296-7. doi: 10.1212/WNL.0b013e3181ecf815. Epub 2010 Jun 30. Neurology. 2010. PMID: 20592252 No abstract available.
Interferon-beta treatment for multiple sclerosis.
Bermel RA, Rudick RA. Bermel RA, et al. Among authors: rudick ra. Neurotherapeutics. 2007 Oct;4(4):633-46. doi: 10.1016/j.nurt.2007.07.001. Neurotherapeutics. 2007. PMID: 17920544 Free PMC article. Review.
Pharmacotherapy of multiple sclerosis: current status.
Rudick RA, Goodkin DE, Ransohoff RM. Rudick RA, et al. Cleve Clin J Med. 1992 May-Jun;59(3):267-77. doi: 10.3949/ccjm.59.3.267. Cleve Clin J Med. 1992. PMID: 1516215 Free article. Review.
Developing a mentorship program for clinical researchers.
Blixen CE, Papp KK, Hull AL, Rudick RA, Bramstedt KA. Blixen CE, et al. Among authors: rudick ra. J Contin Educ Health Prof. 2007 Spring;27(2):86-93. doi: 10.1002/chp.105. J Contin Educ Health Prof. 2007. PMID: 17576629 Review.
229 results